In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Commercialization Alternatives In The New Medtech World

Executive Summary

In the current medtech environment, much attention is paid to evolving strategies to deal with the new challenges private companies are facing in areas like financing and regulatory, and a company’s sales strategy can be left for last or thought to be a topic for an acquirer. The authors describe the challenges that are emerging in the current medtech climate that make an early choice of a sales approach – from a variety of options – an important part of a company’s overall strategy. Not only can the choice of a viable commercialization strategy help drive revenue, it also can increase a company’s valuation at exit.



Related Companies

Related Deals




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts